Novel antidiabetic agents and their effects on lipid Profile: a single shot for several Cardiovascular targets
This distinction is important because while blocking COX-2 provides the anti-inflammatory benefits, blocking COX-1 can lead to side effects like stomach problems (Daniels et al., 2016
Universal GLP-1 coverage for obesity treatment could bankrupt a lot of insurance plans. However, inexpensive weight loss drugs like Alli (orlistat), Adipex-P (phentermine), and Qsymia (phentermine-topiramate) are not always covered by insurance
Wegovy shows liver benefits in ESSENCE trial Novo Nordisk enrolled nearly 1,200 adults with MASH and moderate to advanced fibrosis (stages F2F3)
Vitiello MV, Schwartz RS, Moe KE, Mazzoni G, Merriam GR